Recursion Pharmaceuticals RXRX Earnings Call Transcripts

NASDAQ RXRX
$3.52 +0.02 (+0.57%)
At close: Nov 6, 2026 · 4:00 PM EST
4 earnings calls on file for Recursion Pharmaceuticals, from Q4 2025 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Recursion Pharmaceuticals Q3 2026 Earnings Call

Nov 3, 2026 13,653 words · 59 min read
  • Najat KhanPresident and Chief Executive Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Recursion Pharmaceuticals Earnings Call Transcripts

Calls4
LatestNov 3, 2026
SinceQ4 2025

Fiscal 2026

Fiscal 2025

All 4 Recursion Pharmaceuticals transcripts Register to get access to Recursion Pharmaceuticals’s earnings call transcripts.